Literature DB >> 10336496

High affinity interactions of nucleolin with G-G-paired rDNA.

L A Hanakahi1, H Sun, N Maizels.   

Abstract

Nucleolin is a very abundant eukaryotic protein that localizes to the nucleolus, where the rDNA undergoes transcription, replication, and recombination and where rRNA processing occurs. The top (non-template) strand of the rDNA is very guanine-rich and has considerable potential to form structures stabilized by G-G pairing. We have assayed binding of endogenous and recombinant nucleolin to synthetic oligonucleotides in which G-rich regions have formed intermolecular G-G pairs to produce either two-stranded G2 or four-stranded G4 DNA. We report that nucleolin binds G-G-paired DNA with very high affinity; the dissociation constant for interaction with G4 DNA is KD = 1 nM. Two separate domains of nucleolin can interact with G-G-paired DNA, the four RNA binding domains and the C-terminal Arg-Gly-Gly repeats. Both domains bind G4 DNA with high specificity and recognize G4 DNA structure independent of sequence context. The high affinity of the nucleolin/G4 DNA interaction identifies G-G-paired structures as natural binding targets of nucleolin in the nucleolus. The ability of two independent domains of nucleolin to bind G-G-paired structures suggests that nucleolin can function as an architectural factor in rDNA transcription, replication, or recombination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336496     DOI: 10.1074/jbc.274.22.15908

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  85 in total

1.  Transcriptional activation by LR1 at the Emu enhancer and switch region sites.

Authors:  L A Hanakahi; N Maizels
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

Review 2.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

3.  Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA.

Authors:  Michelle L Duquette; Priya Handa; Jack A Vincent; Andrew F Taylor; Nancy Maizels
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

4.  Genome-wide analysis reveals regulatory role of G4 DNA in gene transcription.

Authors:  Zhuo Du; Yiqiang Zhao; Ning Li
Journal:  Genome Res       Date:  2007-12-20       Impact factor: 9.043

Review 5.  In vivo veritas: using yeast to probe the biological functions of G-quadruplexes.

Authors:  Jay E Johnson; Jasmine S Smith; Marina L Kozak; F Brad Johnson
Journal:  Biochimie       Date:  2008-02-21       Impact factor: 4.079

Review 6.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

7.  Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment.

Authors:  Julie Norseen; F Brad Johnson; Paul M Lieberman
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

8.  Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation.

Authors:  Pooja Rawal; Veera Bhadra Rao Kummarasetti; Jinoy Ravindran; Nirmal Kumar; Kangkan Halder; Rakesh Sharma; Mitali Mukerji; Swapan Kumar Das; Shantanu Chowdhury
Journal:  Genome Res       Date:  2006-05       Impact factor: 9.043

9.  Homologous PNA Hybridization to Noncanonical DNA G-Quadruplexes.

Authors:  Karen A Kormuth; John L Woolford; Bruce A Armitage
Journal:  Biochemistry       Date:  2016-03-16       Impact factor: 3.162

10.  Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation.

Authors:  Jack Zhang; George Tsaprailis; G Tim Bowden
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.